Feasibility trial of UFT [tegafur/uracil] after withdrawal of adjuvant TS-1 [S 1] with adverse effects in patients with curatively resected gastric cancer
Phase of Trial: Phase II
Latest Information Update: 12 May 2016
At a glance
- Drugs Tegafur/uracil (Primary)
- Indications Gastric cancer
- Focus Adverse reactions
- 30 Jan 2010 Status changed from recruiting to suspended as reported by University Hospital Medical Information Network - Japan.
- 29 May 2008 New trial record.